ACCESS Newswire
03 Aug 2022, 19:07 GMT+10
NEW YORK, NY / ACCESSWIRE / August 3, 2022 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.
Apyx Medical Corporation (NASDAQ:APYX)
CONTACT JAKUBOWITZ ABOUT APYX:
https://claimyourloss.com/securities/apyx-medical-corporation-loss-submission-form/?id=30528&from=1
Class Period : May 12, 2021 - March 11, 2022
Lead Plaintiff Deadline : August 5, 2022
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) a significant number of Apyx's Advanced Energy products were used for off-label indications; (2) such off-label uses led to an increase in the number of medical device reports filed by Apyx reporting serious adverse events; (3) as a result, the Company was reasonably likely to incur regulatory scrutiny; (4) as a result of the foregoing, the Company's financial results would be adversely impacted; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Digital Turbine, Inc. (NASDAQ:APPS)
CONTACT JAKUBOWITZ ABOUT APPS:
https://claimyourloss.com/securities/digital-turbine-inc-loss-submission-form/?id=30528&from=1
Class Period : February 26, 2021 - May 31, 2022
Lead Plaintiff Deadline : August 5, 2022
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's recent acquisitions, AdColony and Fyber, act as agents in certain of their respective product lines; (2) as a result, revenues for those product lines must be reported net of license fees and revenue share, rather than on a gross basis; (3) the Company's internal control over financial reporting as to revenue recognition was deficient; and (4) as a result of the foregoing, the Company's net revenues was overstated throughout fiscal 2022; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Verrica Pharmaceuticals, Inc. (NASDAQ:VRCA)
CONTACT JAKUBOWITZ ABOUT VRCA:
https://claimyourloss.com/securities/verrica-pharmaceuticals-inc-loss-submission-form/?id=30528&from=1
Class Period : May 28, 2021 - May 24, 2022
Lead Plaintiff Deadline : August 5, 2022
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) there were manufacturing deficiencies at the facility where Verrica's contract manufacturer produced a bulk solution for the Company's lead product candidate, VP-102; (2) these deficiencies were not remediated when Verrica resubmitted its New Drug Application for VP-12 for molluscum; (3) the foregoing presented significant risks to Verrica obtaining regulatory approval of VP-102 for molluscum; and (4) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
SOURCE : Jakubowitz Law
Get a daily dose of Illinois Intelligencer news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Illinois Intelligencer.
More InformationTORONTO, Canada: Canadian Prime Minister Mark Carney announced late on June 29 that trade negotiations with the U.S. have recommenced...
(250702) -- ATLANTA, July 2, 2025 (Xinhua) -- Supporters of CF Monterrey react before the round of 16 match between Borussia Dortmund...
Washington DC [US], July 2 (ANI): United States President Donald Trump on Tuesday (local time) said that Israel has agreed to the necessary...
Washington DC [US] July 2 (ANI): US President Donald Trump on Tuesday (local time) reaffirmed that India-US will soon strike a trade...
The United States is halting some shipments of weapons previously promised to Ukraine for use in its war with Russia under the Biden...
Washington DC [US], July 2 (ANI): As the US Senate passed the 'One Big Beautiful Bill' with Vice President JD Vance casting the tie-breaking...
EVERGLADES, Florida: Over the weekend, a diverse coalition of environmental activists, Native American leaders, and residents gathered...
BEIJING, China: China's national soccer team may struggle to stir excitement, but its humanoid robots are drawing cheers — and not...
]LONDON, U.K.: A World Health Organization (WHO) expert group investigating the origins of the COVID-19 pandemic released its final...
DOVER, Delaware: California Governor Gavin Newsom has taken legal aim at Fox News, accusing the network of deliberately distorting...
FRANKFURT, Germany: Germany has become the latest country to challenge Chinese AI firm DeepSeek over its data practices, as pressure...
TORONTO, Canada: Harvard University and the University of Toronto have created a backup plan to ensure Harvard graduate students continue...